DanCann Pharma A/S: Notice of extraordinary general meeting
The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (the “Company”), to be held on Tuesday, 20 September 2022 at 10:00 am (CET) at the registered office of the Company, Rugvænget 5, DK-6823 Ansager The agenda for the extraordinary general meeting is as follows: 1. Proposed resolution to authorise the Board of Directors to increase the share capital with pre-emption rights for the Company’s shareholders. 2. Proposed resolution to authorise the Board of Directors to increase the share capital without pre-emption